Shares of Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report) reached a new 52-week high during trading on Monday . The company traded as high as $56.50 and last traded at $56.42, with a volume of 4406 shares traded. The stock had previously closed at $55.94.
Analyst Upgrades and Downgrades
Separately, Royal Bank Of Canada upgraded shares of Sandoz Group from a "hold" rating to a "moderate buy" rating in a research note on Friday, May 2nd.
Read Our Latest Report on Sandoz Group
Sandoz Group Stock Down 1.1%
The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.79 and a current ratio of 1.24. The firm's 50 day simple moving average is $51.63 and its 200 day simple moving average is $46.28.
Sandoz Group Company Profile
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Read More
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
